 MARINA DEL REY, Calif. , Nov. 28, 2022 PRNewswire -- Armata Pharmaceuticals, Inc. NYSE American: ARMP Armata or the Company, a biotechnology company focused on pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections, today announced that the company will participate in the H.C. 